title: Serum erythropoietin levels in patients with severe anemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin in patients with anemia refractory to treatment.
authors.forename: L
authors.initials: L
authors.lastname: Demirtürk
authors.forename: S
authors.initials: S
authors.lastname: Hülagü
authors.forename: M
authors.initials: M
authors.lastname: Yaylaci
authors.forename: M
authors.initials: M
authors.lastname: Altin
authors.forename: M
authors.initials: M
authors.lastname: Ozel
mesh_terms: D000284:Administration, Oral; D000740:Anemia / Q000097:blood* / Q000188:drug therapy / Q000209:etiology*; D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D003093:Colitis, Ulcerative / Q000150:complications; D003424:Crohn Disease / Q000150:complications; D004921:Erythropoietin / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use*; D005296:Ferrous Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D007279:Injections, Subcutaneous; D011994:Recombinant Proteins
chemical_list: D005296:Ferrous Compounds; D011994:Recombinant Proteins; D004921:Erythropoietin; C020748:ferrous sulfate